MIST Milestone Pharmaceuticals Inc. - Common Shares
$1.44
价格 · 五月 20, 2026
截至...的财报数据 五月 13, 2026
52周区间
$1–$3
21% of range
分析师评级
BUY
12 analysts
目标价
$6
+340% upside
P/E (TTM)
-2.7
ROE
-525.0%
净利润率
—
MIST 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.44
市值
$215M
P/E (TTM)
-2.7
每股收益 (TTM)
$-0.75
营收 (TTM)
—
股息收益率
—
ROE
-525.0%
负债/权益
—
52周区间
$1 – $3
MIST 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-0.75
2020-12-31
→
2025-12-31
自由现金流
$-49M
2019-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
指标
5年趋势
MIST
同行中位数
P/E (TTM)
-2.7
—
P/B (市净率)
5.1
0.5
Price / FCF (股价/自由现金流)
-4.3
—
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
MIST
同行中位数
ROA
-66.7%
-73.1%
ROE
-525.0%
-92.8%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
MIST
同行中位数
Current Ratio (流动比率)
8.0
4.8
Quick Ratio (速动比率)
7.6
—
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
MIST
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
MIST
同行中位数
MIST 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
12 位分析师
- 强烈买入 3 25.0%
- 买入 7 58.3%
- 持有 2 16.7%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
6 位分析师 · 2026-05-18
中位数
$7.00
平均值
$6.33
← 低于所有目标
$1.44
最低
$2.00
最高
$8.00
中位数目标
$7.00
+386.1%
平均目标
$6.33
+339.8%
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
平均惊喜
-0.11%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-0.20 | $0.31 | -0.51% |
| 2025年12月31日 | $-0.18 | $-0.16 | -0.02% |
| 2025年9月30日 | $-0.12 | $-0.17 | 0.05% |
| 2025年6月30日 | $-0.20 | $-0.18 | -0.02% |
| 2025年3月31日 | $-0.31 | $-0.19 | -0.12% |
| 2024年12月31日 | $-0.20 | $-0.16 | -0.04% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 11
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $18M | $14M | $31M | $40M | $39M | $34M | $42M | $17M | |
| SG&A Expense | $17M | $17M | $16M | $16M | $12M | $10M | $7M | $3M | |
| Operating Income | $-62M | $-42M | $-61M | $-60M | $-43M | $-51M | $-58M | $-24M | |
| Interest Expense | · | · | $3M | · | · | · | · | · | |
| Interest Income | $3M | $4M | $4M | · | · | · | · | · | |
| Pretax Income | $-63M | $-42M | $-60M | $-58M | $-43M | $-50M | $-55M | $-23M | |
| Income Tax | · | · | · | · | · | $-17.0K | $-56.0K | $74.0K | |
| Net Income | $-63M | $-42M | $-60M | $-58M | $-43M | $-50M | $-55M | $-23M | |
| EPS (Basic) | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 | $-1.70 | · | · | |
| EPS (Diluted) | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 | $-1.70 | · | · | |
| EBITDA | $-62M | $-42M | · | · | $-43M | $-51M | $-58M | · |
资产负债表 22
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $73M | $25M | $14M | $8M | $114M | $72M | $120M | $86M | |
| Short-term Investments | $33M | $44M | $52M | $57M | $0 | $70M | · | $29.0K | |
| Inventory | $648.0K | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $2M | $3M | $6M | $4M | $5M | $2M | $1M | |
| Current Assets | $112M | $74M | $73M | $72M | $119M | $149M | $122M | $88M | |
| PP&E (Net) | $511.0K | $197.0K | $277.0K | $257.0K | $215.0K | $308.0K | $405.0K | $30.0K | |
| PP&E (Gross) | $917.0K | $488.0K | $468.0K | $377.0K | $454.0K | $454.0K | $454.0K | $41.0K | |
| Accum. Depreciation | $406.0K | $291.0K | $191.0K | $120.0K | $239.0K | $146.0K | $49.0K | $11.0K | |
| Total Assets | $114M | $75M | $75M | $74M | $120M | $150M | $123M | $88M | |
| Accounts Payable | $6M | $8M | $7M | $6M | $7M | $6M | $8M | $4M | |
| Accrued Liabilities | $8M | · | · | · | · | · | · | · | |
| Current Liabilities | $14M | $8M | $7M | $6M | $7M | $6M | $8M | $5M | |
| Capital Leases | $539.0K | $874.0K | $1M | $2M | $474.0K | $696.0K | $184.0K | · | |
| Other Non-current Liabilities | $83.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $72M | $62M | $58M | $8M | $7M | $7M | $9M | $5M | |
| Long-term Debt | $57M | $53M | $50M | · | · | · | $0 | · | |
| Common Stock | $353M | $288M | $261M | $274M | $252M | $252M | $226M | $2M | |
| Paid-in Capital | $64M | $40M | $34M | $24M | $16M | $9M | $4M | $3M | |
| Retained Earnings | $-431M | $-368M | $-326M | $-266M | $-208M | $-163M | $-113M | $-58M | |
| Stockholders' Equity | $42M | $13M | $17M | $66M | $113M | $143M | $115M | $84M | |
| Liabilities + Equity | $114M | $75M | $75M | $74M | $120M | $150M | $123M | $88M | |
| Shares Outstanding | 106,236,344 | 53,353,984 | 33,483,111 | 34,286,002 | 29,897,559 | 29,827,997 | 24,505,748 | 596,787 |
现金流 11
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $114.0K | $105.0K | $92.0K | $89.0K | $93.0K | $97.0K | $38.0K | $10.0K | |
| Stock-based Comp | $7M | $6M | $10M | $9M | $7M | $5M | $1M | $633.0K | |
| Other Non-cash | $6M | $7M | · | · | $2M | $-6M | $3M | · | |
| Operating Cash Flow | $-49M | $-29M | $-46M | $-52M | $-33M | $-51M | $-51M | $-21M | |
| CapEx | $302.0K | $33.0K | $112.0K | $272.0K | · | · | $413.0K | $5.0K | |
| Investing Cash Flow | $11M | $8M | $5M | $-57M | $70M | $-70M | $-384.0K | $16M | |
| Stock Issued | $38M | $27M | · | $3M | · | $25M | · | · | |
| Net Stock Activity | $38M | $27M | · | · | · | $25M | · | · | |
| Financing Cash Flow | $86M | $32M | $48M | $3M | $5M | $73M | $85M | $80M | |
| Net Change in Cash | $48M | $12M | $6M | $-107M | $42M | $-48M | $34M | $75M | |
| Free Cash Flow | $-49M | $-29M | · | · | · | · | $-52M | · |
盈利能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -66.7% | -55.1% | · | · | -31.8% | -36.5% | -52.2% | · | |
| ROE | -525.0% | -223.5% | · | · | -35.7% | -40.7% | -44.6% | · | |
| ROIC | · | · | · | · | · | -35.4% | -50.3% | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 9.1 | · | · | 17.6 | 24.1 | 14.7 | · | |
| Quick Ratio | 7.6 | 8.6 | · | · | 16.8 | 23.1 | 14.4 | · |
估值 (TTM) 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-63M | $-42M | $-60M | $-58M | $-43M | $-50M | $-55M | · | |
| Market Cap | $215M | $126M | · | · | $196M | $200M | $392M | · | |
| P/E | -2.7 | -3.5 | -1.2 | -2.9 | -6.4 | -3.9 | · | · | |
| P/B | 5.1 | 9.6 | · | · | 1.7 | 1.4 | 3.4 | · | |
| P / Tangible Book | 5.1 | 9.6 | 3.3 | 2.0 | 1.7 | 1.4 | · | · | |
| P / Cash Flow | -4.4 | -4.4 | · | · | -5.9 | -3.9 | -7.7 | · | |
| P / FCF | -4.3 | -4.4 | · | · | · | · | -7.6 | · | |
| Earnings Yield | -37.1% | -28.4% | -83.2% | -34.8% | -15.6% | -25.4% | · | · |
损益表 11
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| Revenue | $238.0K | |
| Cost of Revenue | $14.0K | |
| R&D Expense | $3M | |
| SG&A Expense | $5M | |
| Operating Expenses | $24M | |
| Operating Income | $-24M | |
| Interest Income | $2M | |
| Net Income | $-26M | |
| EPS (Basic) | $-0.20 | |
| EPS (Diluted) | $-0.20 | |
| EBITDA | $-24M |
资产负债表 21
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| Cash & Equivalents | $71M | |
| Short-term Investments | $113M | |
| Receivables | $2M | |
| Inventory | $2M | |
| Prepaid Expense | $1M | |
| Current Assets | $192M | |
| PP&E (Net) | $500.0K | |
| Total Assets | $194M | |
| Accounts Payable | $10M | |
| Accrued Liabilities | $10M | |
| Current Liabilities | $21M | |
| Capital Leases | $366.0K | |
| Other Non-current Liabilities | $72.0K | |
| Total Liabilities | $158M | |
| Long-term Debt | $58M | |
| Common Stock | $374M | |
| Paid-in Capital | $63M | |
| Retained Earnings | $-457M | |
| Stockholders' Equity | $36M | |
| Liabilities + Equity | $194M | |
| Shares Outstanding | 117,794,417 |
现金流 11
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| D&A | $56.0K | |
| Stock-based Comp | $1M | |
| Other Non-cash | $9M | |
| Operating Cash Flow | $-16M | |
| CapEx | $45.0K | |
| Investing Cash Flow | $-80M | |
| Stock Issued | $11M | |
| Net Stock Activity | $11M | |
| Financing Cash Flow | $94M | |
| Net Change in Cash | $-2M | |
| Free Cash Flow | $-16M |
盈利能力 5
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| Operating Margin | -9942.4% | |
| Net Margin | -10952.1% | |
| EBITDA Margin | -9918.9% | |
| ROA | -20.4% | |
| ROE | -174.2% |
流动性与偿付能力 2
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| Current Ratio | 9.2 | |
| Quick Ratio | 8.9 |
效率 3
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| Asset Turnover | 0.0 | |
| Inventory Turnover | 0.0 | |
| Receivables Turnover | 0.3 |
估值 (TTM) 8
| 指标 | 趋势 | Q1 2026 |
|---|---|---|
| Net Income TTM | $-72M | |
| Market Cap | $140M | |
| P/E | -1.4 | |
| P/B | 3.9 | |
| P / Tangible Book | 3.9 | |
| P / Cash Flow | -8.7 | |
| P / FCF | -8.7 | |
| Earnings Yield | -69.8% |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 净收入 | $-63M | $-42M | $-60M | $-58M | $-43M |
| 稀释后每股收益 (EPS) | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 8.0 | 9.1 | — | — | 17.6 |
| 速动比率 | 7.6 | 8.6 | — | — | 16.8 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-49M | $-29M | — | — | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。